As of 10:10 AM EST. Market Open. NEW HAVEN, Conn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on ...
We recently published a list of 8 Best Small-Cap Growth Stocks to Buy According to Analysts. In this article, we are going to ...
On Wednesday, Arvinas Inc (ARVN) stock saw a modest uptick, ending the day at $27.66 which represents a slight increase of $0.16 or 0.58% from the prior close of $27.5. The stock opened at $27.7 and ...
In this article, we are going to take a look at where Arvinas, Inc. (NASDAQ:ARVN) stands against the other small-cap ...
On Monday, Arvinas Inc (ARVN) stock saw a modest uptick, ending the day at $27.12 which represents a slight increase of $1.20 or 4.63% from the prior close of $25.92. The stock opened at $26.81 and ...
Analysts Are Bullish on These Healthcare Stocks: Arvinas Holding Company (ARVN), 2seventy bio (TSVT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research Report), 2seventy bio (TSVT – Research Report ...
In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Arvinas Holding Company (ARVN – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback